News from xbiotech A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 01, 2015, 15:53 ET
XBiotech Next Generation Antibody Therapy

XBiotech Announces Publication of Positive Clinical Results for Xilonix™ in Non-Small Cell Lung Cancer

 XBiotech Inc., a leading developer of next-generation True Human™ therapeutic antibodies, announced today that results from a subset of...

Mar 12, 2015, 11:41 ET
XBiotech Next Generation Antibody Therapy

XBiotech Launches Website and Call Center to Inform Cancer Patients about New Xilonix™ Therapy and Phase III Clinical Study

 XBiotech announced today that it has launched a website and call center to help patients with metastatic colorectal cancer learn about its...

Mar 04, 2015, 13:42 ET

XBiotech Announces Phase II Psoriasis Study Results in JAMA Dermatology

XBiotech announced today that results from its Phase II pilot study in patients with moderate to severe plaque psoriasis have been published in...

Feb 24, 2015, 12:45 ET

XBiotech Plans to Conduct Initial Public Offering of its Common Stock

XBiotech announced today that it plans to conduct an initial public offering of its common stock. The offering is expected to commence after the...

Nov 04, 2014, 13:24 ET

XBiotech Adds Daniel Vasella to its Board of Directors

 XBiotech announced today that Dr. Daniel Vasella has joined the Company as a member of the Board of Directors. Dr. Vasella was CEO of Sandoz...

Sep 11, 2014, 13:20 ET

XBiotech Purchases Automated Vial Filling Machine, Prompting Increased Manufacturing Capabilities

XBiotech announced today it has taken delivery on its new high throughput filling machine that the Company says will be used to dramatically...

Sep 02, 2014, 14:08 ET

XBiotech Halts Study, Reports Positive Phase III Results with Antibody Therapy for Cancer

 XBiotech announced today interim results from its fast-tracked Phase III study being conducted in the US for its anti-cancer agent...

Aug 01, 2014, 14:31 ET

XBiotech Enrolls First Patient in Phase III European Registration Study Using Xilonix™ for Treatment of Colorectal Cancer

 XBiotech has enrolled the first patient into its European Phase III study using its novel cancer drug Xilonix™ for the treatment of...

Jun 23, 2014, 10:55 ET

XBiotech Announces Addition of Vice President of Clinical Operations

XBiotech announced today that Gary Gonzales has joined the Company as Vice President of Clinical Operations. Mr. Gonzales will lead XBiotech's...

Apr 17, 2014, 12:59 ET

XBiotech Announces Phase I/II Study Results in Lancet Oncology

XBiotech is announcing that results from its Phase I/II oncology study conducted at MD Anderson Cancer Center in Houston, TX were published today...

Apr 15, 2014, 14:03 ET

XBiotech Welcomes Addition of Senior Vice President Corporate Development & General Counsel

XBiotech announced today that Robert Lindsey has joined the Company as Senior Vice President Corporate Development & General Counsel. Mr....

Apr 03, 2014, 14:08 ET

XBiotech Announces In-Licensing Of Technology From Strox Biopharmaceuticals

 XBiotech announced today that it acquired the patent estate of Strox Biopharmaceuticals relating to antibody therapies for methicillin...

Mar 11, 2014, 13:51 ET

XBiotech Issued Patent for Antibody Therapy to Treat Chronic Sterile Inflammatory Diseases

 XBiotech announced today that the United States Patent and Trademark Office (USPTO) granted another key patent to support the Company's...

Jan 30, 2014, 10:50 ET

XBiotech and European Medicines Agency (EMA) Agree on Phase III Registration Study for Treatment of Colorectal Cancer

 XBiotech announced today that its collaboration with the European Medicines Agency (EMA) has resulted in establishment of a regulatory path...

Jan 16, 2014, 15:28 ET

XBiotech Announces Launch of Study to Treat Pyoderma Gangrenosum (PG)

 XBiotech announced today that it has launched a Phase II study to treat a rare but debilitating disorder, Pyoderma Gangrenosum (PG). This...

Sep 18, 2013, 10:00 ET

XBiotech Announces Collaboration with US Oncology Research in Pivotal Phase III Trial for Anti-Cancer Drug Xilonix™

 XBiotech, a privately held biotechnology company, announced today its collaboration with US Oncology Research to conduct a pivotal Phase III...

Sep 04, 2013, 10:50 ET

XBiotech Announces it is Developing Therapy for MRSA

 XBiotech announced today that it has completed discovery and has begun pre-clinical development of a new True Human™ antibody therapy...

Aug 29, 2013, 15:29 ET

XBiotech Announces Addition to its Board of Directors

 XBiotech announced today that Dr. Fabrizio Bonanni has joined the Company as a member of the Board of Directors. Dr. Bonanni joins XBiotech...

May 31, 2013, 10:00 ET

XBiotech Announces Development of A Novel True Human™ Antibody Therapeutic

 XBiotech, a privately held biotechnology company, announced today its development of a novel True Human™ therapeutic antibody. The...

May 15, 2013, 14:15 ET

XBiotech Announces Results for its XILONIX™ Treatment of Non-Small Cell Lung Cancer (NSCLC)

 XBiotech, a privately held biotechnology company, announced today its recent findings for Non-Small Cell Lung Cancer (NSCLC). Sixteen advanced...